HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

GENFLEET-B

25.040

+0.3401.38%

Volume:381.20K

Turnover:9.59M

Market Cap:9.62B

PE:-4.13

High:25.640

Open:24.980

Low:24.920

Close:24.700

52wk High:52.900

52wk Low:19.600

Shares:384.00M

HK Float Shares:352.00M

Volume Ratio:0.85

T/O Rate:0.11%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-6.070

ROE:--

ROA:-12.49%

PB:4.53

PE(LYR):-4.13

PS:63.11

Loading ...

Overview Company News Filings

GenFleet Doses First Patient in China Phase III Trial of KRAS G12D Inhibitor Gfh375 for NSCLC

Genfleet Therapeutics (Shanghai) - Gfh375 Advances to Registrational Phase Iii Study in China for Kras G12d-Mutant Nsclc

THOMSON REUTERS

GenFleet Therapeutics to Hold Board Meeting on Interim Results, Dividend Recommendation

GenFleet Therapeutics Sets 21 Aug 2026 Board Meeting to Approve H1 2026 Interim Results and Dividend Plan

Bulletin Express

GenFleet Therapeutics Issues 13.60 Million New H Shares via HK$34.69 Placing, Lifts Total Issued Shares to 351.63 Million

Bulletin Express

Analysts Are Bullish on These NA Stocks: Guming Holdings Ltd. (HK:1364), Genfleet Therapeutics (Shanghai), Inc. Class H (HK:2595)

Movement Alert｜GENFLEET-B Rises 5.45% in Regular Trading, Trading at HK$28.34

Movement Alert｜GENFLEET-B Falls 5.41% in Regular Trading, Competitor RAS Inhibitor NDA Accepted by FDA Continues to Weigh on Shares

Movement Alert｜GENFLEET-B Falls 5.49% in Regular Trading, Competitor RAS Inhibitor NDA Accepted by FDA Continues to Pressure Pipeline

Movement Alert｜GENFLEET-B Intraday Decline 5.12%, Competitor Revolution Medicines RAS Inhibitor NDA Accepted by FDA Sparks Competition Concerns

Wellington Management Group LLP Reduces Stake in GENFLEET-B by 8,400 Shares at HK$34.71 Per Share

Movement Alert｜GenFleet Therapeutics-B Rises 5.76% in Regular Trading, Technical Recovery Following H-Share Placement Completion

Wellington Management Group LLP Boosts Stake in GENFLEET-B with Share Purchase

GenFleet Therapeutics completes HK$466.90 million H-share placing and updates share capital structure

Bulletin Express

GENFLEET-B Successfully Places 13.6 Million Shares, Raising Approximately HK$467 Million Net

Genfleet Therapeutics Completes Placement of 13,600,000 New H Shares at HK$ 34.69 Each

Movement Alert｜GenFleet Therapeutics-B Declines 8.2% in Regular Trading, Biotech Sector Under Broad Pressure After Prior Rally

GenFleet Therapeutics Seeks HK$467 Million via H-Share Placement; Shares Up 11%

MT Newswires Live

GENFLEET-B Announces Private Placement of 13.6 Million Shares at Approximately 9.71% Discount, Raising Net Proceeds of HK$467 Million

Genfleet Therapeutics Prices 13,600,000-share H-share Placement at HK$ 34.69 Each

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigerfiesta.com/stock/02595/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02595","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02595\",,,,,undefined,":{"symbol":"02595","market":"HK","secType":"STK","nameCN":"GENFLEET-B","latestPrice":25.04,"timestamp":1789622501243,"preClose":24.7,"halted":0,"volume":381200,"delay":0,"changeRate":0.013765182186234813,"floatShares":352000000,"shares":384000000,"eps":-6.07,"marketStatus":"Trading","change":0.34,"latestTime":"09-17 13:22:05","open":24.98,"high":25.64,"low":24.92,"amount":9588864,"amplitude":0.02915,"askPrice":25.04,"askSize":4000,"bidPrice":25.02,"bidSize":200,"shortable":3,"etf":0,"ttmEps":-3.946,"tradingStatus":2,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1789632600000},"marketStatusCode":2,"adr":0,"listingDate":1758211200000,"exchange":"SEHK","adjPreClose":24.7,"openAndCloseTimeList":[[1789608600000,1789617600000],[1789621200000,1789632000000]],"volumeRatio":0.848358,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02595\",,,,,undefined,":{"symbol":"02595","floatShares":352000000,"roa":"-12.49%","roe":"--","lyrEps":-6.07,"volumeRatio":0.848358,"shares":384000000,"dividePrice":0,"high":25.64,"amplitude":0.02915,"preClose":24.7,"low":24.92,"week52Low":19.6,"pbRate":"4.53","psRate":"63.11","week52High":52.9,"institutionHeld":0,"latestPrice":25.04,"committee":-0.904762,"eps":-6.07,"divideRate":0,"volume":381200,"delay":0,"ttmEps":-3.946,"open":24.98,"prevYearClose":23.78,"prevWeekClose":25.48,"prevMonthClose":30.8,"prevQuarterClose":29.44,"fiveDayClose":25.96,"twentyDayClose":32.74,"sixtyDayClose":27.5},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02595\",params:#limit:5,,,undefined,":[{"date":"2026-08-21","symbol":"02595","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787275800000,"name":null,"time":"","dateTimestamp":1787241600000,"actualEps":null},{"date":"2026-03-24","symbol":"02595","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774315800000,"name":null,"time":"","dateTimestamp":1774281600000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02595\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02595\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.4,"buy":0.6,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6,"analysts":5,"updateTime":1788105600000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02595\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02595","date":"2026-09-15","current":-6.259503,"percent":0.983333,"low":-19.62221,"twenty":-10.721918,"median":-9.519592,"eighty":-7.067323,"high":-5.69787,"avg":-9.381194,"sd":2.67468,"marketCap":9444349065},"quantilePoints":[{"date":"2025-09-19","current":-19.62221,"twenty":-19.62221,"median":-19.62221,"eighty":-19.62221,"marketCap":14538840523},{"date":"2025-09-26","current":-17.850791,"twenty":-18.989349,"median":-18.569255,"eighty":-18.336187,"marketCap":13192012066},{"date":"2025-10-03","current":-19.06699,"twenty":-19.162092,"median":-18.845312,"eighty":-18.417026,"marketCap":14124431767},{"date":"2025-10-10","current":-11.809112,"twenty":-19.045684,"median":-18.645404,"eighty":-16.087956,"marketCap":11948785798},{"date":"2025-10-17","current":-10.861917,"twenty":-19.006201,"median":-18.336187,"eighty":-11.374297,"marketCap":10981832034},{"date":"2025-10-24","current":-9.567304,"twenty":-18.816504,"median":-12.899451,"eighty":-10.554523,"marketCap":9676444452},{"date":"2025-10-31","current":-9.989391,"twenty":-18.681528,"median":-11.762498,"eighty":-10.081819,"marketCap":10118416331},{"date":"2025-11-07","current":-9.878556,"twenty":-18.646705,"median":-10.725216,"eighty":-9.89625,"marketCap":9999899010},{"date":"2025-11-14","current":-11.674836,"twenty":-18.558233,"median":-10.712517,"eighty":-9.936062,"marketCap":11851732160},{"date":"2025-11-21","current":-10.329745,"twenty":-18.396816,"median":-10.725216,"eighty":-10.005136,"marketCap":10481375629},{"date":"2025-11-28","current":-10.423287,"twenty":-18.142029,"median":-10.678396,"eighty":-10.044836,"marketCap":10614707615},{"date":"2025-12-05","current":-10.100425,"twenty":-16.087956,"median":-10.631034,"eighty":-10.044836,"marketCap":10303599646},{"date":"2025-12-12","current":-10.212238,"twenty":-13.008301,"median":-10.584309,"eighty":-10.020393,"marketCap":10436931633},{"date":"2025-12-19","current":-9.790532,"twenty":-12.136764,"median":-10.450758,"eighty":-9.957409,"marketCap":10029528340},{"date":"2025-12-24","current":-8.945585,"twenty":-11.809112,"median":-10.416014,"eighty":-9.900509,"marketCap":9192499756},{"date":"2026-01-02","current":-8.020182,"twenty":-11.73453,"median":-10.320373,"eighty":-9.861601,"marketCap":8273990514},{"date":"2026-01-09","current":-11.588563,"twenty":-11.683046,"median":-10.309663,"eighty":-9.776189,"marketCap":11985064146},{"date":"2026-01-16","current":-11.693807,"twenty":-11.67863,"median":-10.369243,"eighty":-9.793132,"marketCap":12133210798},{"date":"2026-01-23","current":-10.361602,"twenty":-11.605818,"median":-10.329745,"eighty":-9.783265,"marketCap":10740632270},{"date":"2026-01-30","current":-10.919089,"twenty":-11.483053,"median":-10.385171,"eighty":-9.793132,"marketCap":11370255541},{"date":"2026-02-06","current":-11.146899,"twenty":-11.598147,"median":-10.450758,"eighty":-9.8258,"marketCap":11636919514},{"date":"2026-02-13","current":-10.659945,"twenty":-11.483053,"median":-10.58187,"eighty":-9.869606,"marketCap":11192479558},{"date":"2026-02-20","current":-10.145441,"twenty":-11.446311,"median":-10.573435,"eighty":-9.881527,"marketCap":10636929613},{"date":"2026-02-27","current":-9.574146,"twenty":-11.38719,"median":-10.509847,"eighty":-9.836956,"marketCap":10148045662},{"date":"2026-03-06","current":-8.841756,"twenty":-11.29428,"median":-10.416014,"eighty":-9.744297,"marketCap":9296202413},{"date":"2026-03-13","current":-10.316011,"twenty":-11.38719,"median":-10.450758,"eighty":-9.761464,"marketCap":10896186254},{"date":"2026-03-20","current":-10.186272,"twenty":-11.29428,"median":-10.385171,"eighty":-9.744297,"marketCap":10718410272},{"date":"2026-03-27","current":-5.945762,"twenty":-11.270982,"median":-10.329745,"eighty":-9.723416,"marketCap":12081359470},{"date":"2026-04-02","current":-6.621163,"twenty":-11.205287,"median":-10.312136,"eighty":-9.574146,"marketCap":13518381995},{"date":"2026-04-10","current":-7.067323,"twenty":-11.18954,"median":-10.310332,"eighty":-9.547859,"marketCap":14540593893},{"date":"2026-04-17","current":-8.194366,"twenty":-11.170082,"median":-10.271344,"eighty":-9.114302,"marketCap":16866496330},{"date":"2026-04-24","current":-11.736244,"twenty":-11.170082,"median":-10.248784,"eighty":-8.950161,"marketCap":18318333519},{"date":"2026-04-30","current":-10.233962,"twenty":-11.173069,"median":-10.230093,"eighty":-8.995356,"marketCap":15977616418},{"date":"2026-05-08","current":-9.881779,"twenty":-11.158327,"median":-10.186272,"eighty":-9.095725,"marketCap":15481325134},{"date":"2026-05-15","current":-8.422278,"twenty":-11.148553,"median":-10.161068,"eighty":-8.948635,"marketCap":13229496023},{"date":"2026-05-22","current":-7.916926,"twenty":-11.098455,"median":-10.138144,"eighty":-8.800358,"marketCap":12407282105},{"date":"2026-05-29","current":-8.035507,"twenty":-11.019944,"median":-10.082937,"eighty":-8.624127,"marketCap":12636909415},{"date":"2026-06-05","current":-6.909175,"twenty":-10.994143,"median":-10.039967,"eighty":-8.441141,"marketCap":10881371589},{"date":"2026-06-12","current":-6.584396,"twenty":-10.981505,"median":-9.989391,"eighty":-8.291507,"marketCap":10362858307},{"date":"2026-06-18","current":-6.718884,"twenty":-10.969649,"median":-9.941921,"eighty":-8.193596,"marketCap":10599892950},{"date":"2026-06-26","current":-5.732708,"twenty":-10.937065,"median":-9.927249,"eighty":-8.035507,"marketCap":8999909109},{"date":"2026-07-03","current":-7.180567,"twenty":-10.922684,"median":-9.900616,"eighty":-7.915515,"marketCap":11281367549},{"date":"2026-07-10","current":-9.054005,"twenty":-10.894174,"median":-9.893411,"eighty":-7.915515,"marketCap":14207263926},{"date":"2026-07-17","current":-8.396292,"twenty":-10.887172,"median":-9.884317,"eighty":-7.956496,"marketCap":13222088691},{"date":"2026-07-24","current":-8.187485,"twenty":-10.884642,"median":-9.862553,"eighty":-8.009423,"marketCap":12896166056},{"date":"2026-07-31","current":-6.510345,"twenty":-10.870773,"median":-9.833804,"eighty":-7.907869,"marketCap":10273970316},{"date":"2026-08-07","current":-7.003679,"twenty":-10.846908,"median":-9.792157,"eighty":-7.575355,"marketCap":11073962237},{"date":"2026-08-14","current":-7.214728,"twenty":-10.805358,"median":-9.754197,"eighty":-7.296139,"marketCap":11422106869},{"date":"2026-08-21","current":-7.917767,"twenty":-10.771121,"median":-9.6954,"eighty":-7.255608,"marketCap":12562836089},{"date":"2026-08-28","current":-7.346545,"twenty":-10.748709,"median":-9.635917,"eighty":-7.293508,"marketCap":11659141512},{"date":"2026-09-04","current":-6.41515,"twenty":-10.730984,"median":-9.570725,"eighty":-7.1768,"marketCap":10185082325},{"date":"2026-09-11","current":-5.935917,"twenty":-10.723237,"median":-9.522333,"eighty":-7.102704,"marketCap":9436941732},{"date":"2026-09-15","current":-5.941544,"twenty":-10.721918,"median":-9.519592,"eighty":-7.067323,"marketCap":9444349065}],"updateTime":1789582579099},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02595\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2658056066","title":"GenFleet Doses First Patient in China Phase III Trial of KRAS G12D Inhibitor Gfh375 for NSCLC","url":"https://stock-news.laohu8.com/highlight/detail?id=2658056066","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658056066?lang=en_us&edition=fundamental","pubTime":"2026-08-10 08:01","pubTimestamp":1786320110,"startTime":"0","endTime":"0","summary":"GenFleet doses first patient in China Phase III trial of KRAS G12D inhibitor GFH375 for NSCLCGenFleet started a registrational Phase III China trial of oral KRAS G12D inhibitor GFH375 in previously tr","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nNDL50jB2g:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02595","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658605675","title":"Genfleet Therapeutics (Shanghai) - Gfh375 Advances to Registrational Phase Iii Study in China for Kras G12d-Mutant Nsclc","url":"https://stock-news.laohu8.com/highlight/detail?id=2658605675","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658605675?lang=en_us&edition=fundamental","pubTime":"2026-08-10 08:01","pubTimestamp":1786320088,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nFWN4450BY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02595","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657572308","title":"GenFleet Therapeutics to Hold Board Meeting on Interim Results, Dividend Recommendation","url":"https://stock-news.laohu8.com/highlight/detail?id=2657572308","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657572308?lang=en_us&edition=fundamental","pubTime":"2026-08-06 07:05","pubTimestamp":1785971114,"startTime":"0","endTime":"0","summary":"GenFleet Therapeutics to hold board meeting on interim results, dividend recommendationGenfleet Therapeutics schedules a board meeting for Aug. 21, 2026 to review interim results for the six months en","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nNDL6CxlVg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02595"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1124539406","title":"GenFleet Therapeutics Sets 21 Aug 2026 Board Meeting to Approve H1 2026 Interim Results and Dividend Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=1124539406","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1124539406?lang=en_us&edition=fundamental","pubTime":"2026-08-06 06:08","pubTimestamp":1785967687,"startTime":"0","endTime":"0","summary":"GenFleet Therapeutics (Shanghai) Inc. announced that its board of directors will convene on 21 August 2026. The meeting agenda includes: • Reviewing and approving the consolidated interim results for...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02595"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111499452","title":"GenFleet Therapeutics Issues 13.60 Million New H Shares via HK$34.69 Placing, Lifts Total Issued Shares to 351.63 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1111499452","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1111499452?lang=en_us&edition=fundamental","pubTime":"2026-08-05 17:29","pubTimestamp":1785922141,"startTime":"0","endTime":"0","summary":"GenFleet Therapeutics (Shanghai) Inc. completed the allotment of 13.60 million new H shares on 17 July 2026 at HK$34.69 per share under a general mandate, according to the company’s Monthly Return...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02595"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657512518","title":"Analysts Are Bullish on These NA Stocks: Guming Holdings Ltd. (HK:1364), Genfleet Therapeutics (Shanghai), Inc. Class H (HK:2595)","url":"https://stock-news.laohu8.com/highlight/detail?id=2657512518","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657512518?lang=en_us&edition=fundamental","pubTime":"2026-08-05 17:01","pubTimestamp":1785920460,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the NA sector as 2 analysts just weighed in on Guming Holdings Ltd. (HK:1364) and Genfleet Therapeutics (Sh...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-na-stocks-guming-holdings-ltd-hk1364-genfleet-therapeutics-shanghai-inc-class-h-hk2595-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-na-stocks-guming-holdings-ltd-hk1364-genfleet-therapeutics-shanghai-inc-class-h-hk2595-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0211977185.USD","02595","BK1616","LU2488822045.USD","BK1233","BK1161","01364","LU2279858448.HKD","LU1171460220.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169206809","title":"Movement Alert｜GENFLEET-B Rises 5.45% in Regular Trading, Trading at HK$28.34","url":"https://stock-news.laohu8.com/highlight/detail?id=1169206809","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1169206809?lang=en_us&edition=fundamental","pubTime":"2026-07-31 10:33","pubTimestamp":1785465193,"startTime":"0","endTime":"0","summary":"On July 31, GENFLEET-B rose 5.45% in regular trading, trading at HK$28.34/share, with turnover of HK$27.97 million.Within the Biotechnology sector where GENFLEET-B belongs, individual stocks showed...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02595"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191917468","title":"Movement Alert｜GENFLEET-B Falls 5.41% in Regular Trading, Competitor RAS Inhibitor NDA Accepted by FDA Continues to Weigh on Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=1191917468","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1191917468?lang=en_us&edition=fundamental","pubTime":"2026-07-30 11:25","pubTimestamp":1785381903,"startTime":"0","endTime":"0","summary":"On July 30, GENFLEET-B fell 5.41% in regular trading to HK$26.32, with turnover of approximately HK$21.70 million, marking the third consecutive trading day of decline.On the news front, competitor...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"GENFLEET-B Falls; Competitor RAS Inhibitor NDA Accepted by FDA Continues to Weigh on Shares","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02595"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1139222405","title":"Movement Alert｜GENFLEET-B Falls 5.49% in Regular Trading, Competitor RAS Inhibitor NDA Accepted by FDA Continues to Pressure Pipeline","url":"https://stock-news.laohu8.com/highlight/detail?id=1139222405","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1139222405?lang=en_us&edition=fundamental","pubTime":"2026-07-29 10:00","pubTimestamp":1785290416,"startTime":"0","endTime":"0","summary":"On July 29, GENFLEET-B fell 5.49% in regular trading, trading at 27.08 HKD/share with turnover of 16.95 million HKD, extending the previous session's decline.On the news front, competitor Revolution...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"GENFLEET-B Falls; Competitor RAS Inhibitor NDA Accepted by FDA Continues to Pressure Pipeline","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02595"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1178553338","title":"Movement Alert｜GENFLEET-B Intraday Decline 5.12%, Competitor Revolution Medicines RAS Inhibitor NDA Accepted by FDA Sparks Competition Concerns","url":"https://stock-news.laohu8.com/highlight/detail?id=1178553338","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1178553338?lang=en_us&edition=fundamental","pubTime":"2026-07-28 10:11","pubTimestamp":1785204674,"startTime":"0","endTime":"0","summary":"On July 28, GENFLEET-B declined 5.12% in regular trading, trading at HK$31.54/share, with turnover of HK$10.16 million.On the news front, competitor Revolution Medicines announced that its oral RAS...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"GENFLEET-B Decline as Competitor Revolution Medicines RAS Inhibitor NDA Accepted by FDA","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02595"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1137092944","title":"Wellington Management Group LLP Reduces Stake in GENFLEET-B by 8,400 Shares at HK$34.71 Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=1137092944","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1137092944?lang=en_us&edition=fundamental","pubTime":"2026-07-22 19:38","pubTimestamp":1784720300,"startTime":"0","endTime":"0","summary":"According to the latest data from the Hong Kong Stock Exchange, on July 20th, Wellington Management Group LLP sold 8,400 shares of GENFLEET-B (02595) at an average price of HK$34.7105 per share. The...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09939","EWH","BK1574","02595","BK1515","159938","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184812440","title":"Movement Alert｜GenFleet Therapeutics-B Rises 5.76% in Regular Trading, Technical Recovery Following H-Share Placement Completion","url":"https://stock-news.laohu8.com/highlight/detail?id=1184812440","media":"Market Focus","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1184812440?lang=en_us&edition=fundamental","pubTime":"2026-07-21 13:28","pubTimestamp":1784611716,"startTime":"0","endTime":"0","summary":"On July 21, GenFleet Therapeutics-B rose 5.76% in regular trading, trading at 38.2 HKD/share, with turnover of approximately HKD 26.46 million. The stock is staging a technical recovery above the...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02595"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1171595661","title":"Wellington Management Group LLP Boosts Stake in GENFLEET-B with Share Purchase","url":"https://stock-news.laohu8.com/highlight/detail?id=1171595661","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1171595661?lang=en_us&edition=fundamental","pubTime":"2026-07-17 20:20","pubTimestamp":1784290851,"startTime":"0","endTime":"0","summary":"According to the latest data from the Hong Kong Stock Exchange, Wellington Management Group LLP increased its holding in GENFLEET-B (02595) on July 15. The firm purchased 1.3974 million shares at a...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09939","02595","BK1574","BK1515","159938","BK1161","EWH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1183578809","title":"GenFleet Therapeutics completes HK$466.90 million H-share placing and updates share capital structure","url":"https://stock-news.laohu8.com/highlight/detail?id=1183578809","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1183578809?lang=en_us&edition=fundamental","pubTime":"2026-07-17 20:02","pubTimestamp":1784289741,"startTime":"0","endTime":"0","summary":"GenFleet Therapeutics (Shanghai) Inc. announced the successful completion of its previously disclosed H-share placing on 17 July 2026. All conditions under the placing agreement have been met, and...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02595"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113605298","title":"GENFLEET-B Successfully Places 13.6 Million Shares, Raising Approximately HK$467 Million Net","url":"https://stock-news.laohu8.com/highlight/detail?id=1113605298","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1113605298?lang=en_us&edition=fundamental","pubTime":"2026-07-17 19:40","pubTimestamp":1784288425,"startTime":"0","endTime":"0","summary":"The share placement agreement for GENFLEET-B (02595) has met all stipulated conditions, with settlement completed on July 17, 2026, in accordance with the agreement's terms.The placement agent...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02595","BK1515","BK1161","09939","159938","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652400974","title":"Genfleet Therapeutics Completes Placement of 13,600,000 New H Shares at HK$ 34.69 Each","url":"https://stock-news.laohu8.com/highlight/detail?id=2652400974","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652400974?lang=en_us&edition=fundamental","pubTime":"2026-07-17 19:32","pubTimestamp":1784287970,"startTime":"0","endTime":"0","summary":"GenFleet Therapeutics completes placement of 13,600,000 new H shares at HK$ 34.69 eachGenFleet Therapeutics completed a private placement of 13,600,000 new H shares at HK$ 34.69 each on July 17, 2026.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260717:nNDL1pmFyr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02595","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1141284875","title":"Movement Alert｜GenFleet Therapeutics-B Declines 8.2% in Regular Trading, Biotech Sector Under Broad Pressure After Prior Rally","url":"https://stock-news.laohu8.com/highlight/detail?id=1141284875","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1141284875?lang=en_us&edition=fundamental","pubTime":"2026-07-17 11:11","pubTimestamp":1784257910,"startTime":"0","endTime":"0","summary":"On July 17, GenFleet Therapeutics-B fell 8.2% in regular trading, trading at HK$35.88/share, with turnover of HK$38.47 million.The decline came as the broader biotechnology sector faced significant...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02595"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651239434","title":"GenFleet Therapeutics Seeks HK$467 Million via H-Share Placement; Shares Up 11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2651239434","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651239434?lang=en_us&edition=fundamental","pubTime":"2026-07-15 14:08","pubTimestamp":1784095697,"startTime":"0","endTime":"0","summary":"GenFleet Therapeutics   is seeking to raise net proceeds of about HK$466.9 million through the placement of 13.6 million new H-shares, according to a Hong Kong bourse filing on Wednesday.The company is offering the shares at HK$34.69 each, representing a 9.71% discount to the last closing price.The net proceeds will primarily be used to advance the clinical development of its RAS inhibitor pipeline, enhance its research and development platforms, and for working capital and general corporate purposes.The new shares represent about 3.67% of the company's existing issued share capital and about 3.54% of its enlarged share capital after the placement.Shares of the biopharmaceutical company were up over 11% in Wednesday afternoon trade.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","BK1161","BK4139","02595","BK4539","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158451861","title":"GENFLEET-B Announces Private Placement of 13.6 Million Shares at Approximately 9.71% Discount, Raising Net Proceeds of HK$467 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1158451861","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1158451861?lang=en_us&edition=fundamental","pubTime":"2026-07-15 07:28","pubTimestamp":1784071706,"startTime":"0","endTime":"0","summary":"GENFLEET-B (ASX: 02595) has entered into a share placement agreement, according to a company announcement. The agreement, signed with a placement agent after market hours on July 14, 2026, involves...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02595","BK1161","BK1574","159938","09939","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651148210","title":"Genfleet Therapeutics Prices 13,600,000-share H-share Placement at HK$ 34.69 Each","url":"https://stock-news.laohu8.com/highlight/detail?id=2651148210","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651148210?lang=en_us&edition=fundamental","pubTime":"2026-07-15 07:21","pubTimestamp":1784071289,"startTime":"0","endTime":"0","summary":"GenFleet Therapeutics prices 13,600,000-share H-share placement at HK$ 34.69 eachGenFleet Therapeutics (Shanghai) agreed a private placement of 13,600,000 new H shares at HK$ 34.69 each.Deal size HK$ ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260714:nNDL44QlCm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2271345857.HKD","IAI","LU2111349929.HKD","LU0912757837.SGD","BK4588","BK4585","LU1720051017.SGD","LU1997244956.HKD","LU1244550577.SGD","LU1988902786.USD","LU0882574139.USD","LU1064131003.USD","LU0528227936.USD","LU1732800096.USD","BK4534","LU2028103732.USD","LU0267386448.USD","LU2148510915.USD","LU1989772840.SGD","BK0028","LU0405327148.USD","IE00BZ1G4Q59.USD","LU1162221912.USD","LU2347655156.SGD","LU1548497426.USD","LU2133065610.SGD","LU0098860793.USD","02595","KBWB","BK0183","LU1074936037.SGD","LU1328615791.USD","LU1655091616.SGD","LU1791710400.SGD","BK0188","LU1064131342.USD","LU0234570918.USD","LU0795875169.SGD","LU2089283258.USD","BK4504","IE00BKVL7J92.USD","LU0405327494.USD","BK4516","LU1580142542.USD","LU0390134368.USD","LU2264538146.SGD","600030","LU1781817850.SGD","LU1720051108.HKD","LU0320765646.SGD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":3,"totalSize":117,"code":"91000000","status":"200"}]}}